Manufacturer: Deus Medical, Europe
Pharmaceutical name: Delta Sleep-Inducing Peptide
Pack: 1 vial (5 mg)
DSIP (Delta Sleep-Inducing Peptide) is a peptide that enhances Delta wave activity, crucial for deep sleep. It is predominantly present in human breast milk. This peptide can aid in treating conditions like insomnia, narcolepsy, convulsions, as well as opioid and alcohol withdrawal. Additionally, it helps alleviate stress, depression, and anxiety. It is available as Delta Sleep-Inducing Peptides in a 5mg/vial form, containing 5mg of the peptide along with excipients.
Mechanism of Action of DSIP (Delta Sleep-Inducing Peptide).
Research indicates that DSIP decreases the nocturnal activity of the enzyme NAT and may play a role in modulating adrenergic transmission. Moreover, it acts as an antagonist at opiate receptors, making it effective in managing alcohol and opiate withdrawal syndromes.
Dosage of DSIP (Delta Sleep-Inducing Peptide):
Inject 0.1ml subcutaneously at bedtime.
Side Effects of DSIP (Delta Sleep-Inducing Peptide):
Possible headache, nausea, fatigue, and dizziness.
Interactions of DSIP (Delta Sleep-Inducing Peptide):
May interact with Dexamethasone and exogenous hormones.